Clinuvel Pharmaceuticals (UR9A.F) Q3 2022 Earnings

30AugConfirmed
Q1 2021
Q3 2021
Q1 2022
Q3 2022
0.07
0.12
0.17
0.22

Details

Expected EPS
0.19833104772353263
Actual EPS
0.19833104772353263
Surprise EPS
0
Surprise Percent
+0%

Description

Clinuvel Pharmaceuticals (UR9A.F) has reported earnings of 0.19833104772353263 per share for Q3 2022.

0 Comments

Share your thoughts